Open AWE Magazine menu
Subscribe Login

Home / Articles and Press Releases / Article / What’s in the Water?

CATEGORIES

  • Latest Issue
  • Air Quality
  • Chromatography
  • Construction
  • Climate Change
  • Emissions
  • Environmental & Monitoring Technology
  • Gas Detection
  • Health and Safety Awareness
  • Humidity & Temperature
  • Laboratory Testing
  • Land Remediation
  • Marine Pollution
  • Noise Monitoring
  • Regulations & Legislations
  • Sludge and Biosolids
  • Soil Analysis
  • Spectroscopy
  • Weather Monitoring
  • Water Analysis
  • Water Monitoring

MORE

  • Press Releases
  • Events
  • Videos
  • Magazines

COMPANY

  • About
  • Advertising
  • Newsletter
  • Contact
HSI White logo
Open AWE Magazine menu
Subscribe

Home / Articles and Press Releases / Article / What’s in the Water?

CATEGORIES

  • Latest Issue
  • Air Quality
  • Chromatography
  • Construction
  • Climate Change
  • Emissions
  • Environmental & Monitoring Technology
  • Gas Detection
  • Health and Safety Awareness
  • Humidity & Temperature
  • Laboratory Testing
  • Land Remediation
  • Marine Pollution
  • Noise Monitoring
  • Regulations & Legislations
  • Sludge and Biosolids
  • Soil Analysis
  • Spectroscopy
  • Weather Monitoring
  • Water Analysis
  • Water Monitoring

MORE

  • Press Releases
  • Events
  • Videos
  • Magazines

COMPANY

  • About
  • Advertising
  • Newsletter
  • Contact

CATEGORIES

  • Heat and Flame
  • Press Release|Gas Detection
  • Article
  • Press Release
  • Air Quality
  • Chromatography
  • Construction
  • Climate Change
  • Emissions
  • Environmental & Monitoring Technology
  • Gas Detection
  • Health and Safety Awareness
  • Humidity & Temperature
  • Laboratory Testing
  • Land Remediation
  • Marine Pollution
  • Noise Monitoring
  • Personal Protective Equipment
  • Regulations & Legislations
  • Sludge and Biosolids
  • Soil Analysis
  • Spectroscopy
  • Weather Monitoring
  • Water Analysis
  • Water Monitoring
  • Wellbeing at work

Article

What’s in the Water?

What’s in the Water?

By Carla Nassour MSc | Prof James Barker | Dr Shereen Nabhani-Gebara | Dr Stephen J. Barton | School of Life Sciences, Pharmacy and Chemistry, Kingston University, London

| Read Bio

Published: May 04th, 2022

Share this article

With the advent of increasingly specific and efficient analytical techniques, the detection of trace concentrations of numerous compounds has been made possible. This has helped us better understand the impact trace pharmaceuticals are having on the environment – as well as highlighting how much more needs to be done to tackle the problem. 

The occurrence of pharmaceuticals in rivers and lakes is mainly due to the inability of water treatment plants to remove these compounds efficiently before being released. Responding to growing concerns, the European Commission has put together a Watch List to be updated every two years, including 14 pharmaceuticals that are potential water contaminants. The idea behind this work is to determine whether the pharmaceuticals in question pose any threat to the environment. If so, a concentration limit would be set for them at EU level, known as environmental quality standards.

Although this is a great initiative to reduce the contamination impact on the aquatic environment, there are many other classes of pharmaceuticals, such as anticancer drugs, that are prescribed and administered daily, yet are not being addressed.

Cancer and Anticancer Drugs

Cancer is a leading cause of death worldwide, with approximately 10 million deaths in 2020. Given the increased incidence of cancer rates every year, the production and consumption of anticancer drugs are unsurprisingly on the rise.

What’s in the Water?

Anticancer drugs have been used clinically since the 1940s. They can be classified according to their chemical structures, their mode of action or the cell cycle specificity. In the Anatomical Therapeutic Chemical (ATC) classification, anticancer drugs are categorised into two groups:

  1. Antineoplastic agents, which includes alkylating agents, antimetabolites, plant alkaloids and other natural products, cytotoxic antibiotics and related substances, protein kinase inhibitors, monoclonal antibodies and antibody-drug conjugates and other antineoplastic agents
  2. Endocrine therapy, which includes hormones and hormone antagonists

These drugs can be administered in a variety of ways, including intravenously, orally, intramuscularly and intrathecally. In the treatment regimen, one or several anticancer drugs can be prescribed (known as ‘combination chemotherapy’) depending on the patient and stage of cancer. To increase the effectiveness of the treatment, drugs from different categories can be included in the regimen to treat the same type of cancer. In the table below, the mode of action of each category is described with examples of different drugs used to treat different types of cancers.

What’s in the Water?

“pharmaceuticals in rivers and lakes are mainly due to the inability of water treatment plants to remove these compounds efficiently”

Metabolism of Anticancer Drugs 

As with many other pharmaceuticals, anticancer drugs are metabolised in the organism after absorption by Phase I and/or Phase II reactions. Phase I reactions include oxidation, reduction and hydrolysis, which will reduce the activity of the drug or, in some cases, aim to increase it if the parent compound is inactive. The Phase I metabolisation process will introduce functional groups such as hydroxyl, amino and carboxyl to the parent compound (Carboxycyclophosphamide, 4-Hydroxytamoxifen, 2,7-Diaminomitosene). In Phase II reactions, the parent compound or the Phase I metabolite undergo conjugation reactions that include glucuronidation, sulfonation, glycine/glutamine conjugation, acetylation, methylation, and glutathione conjugation. These reactions induce the inactivation of the compound before excretion. However, in some cases, Phase II reactions generate active metabolites, such as with the anticancer drugs tamoxifen and capecitabine, so the metabolism of anticancer drugs can produce inactive metabolites, as well as active and toxic metabolites. These latter metabolites are excreted after Phase I or Phase II reactions via the biliary tract or kidneys.

What’s in the Water?

Examples of high excretion rates of anticancer drugs include gemcitabine with 92 to 98 per cent excretion in urine, megestrol with 66 per cent in urine and 20 per cent in faeces, methotrexate with 60 to 95 per cent in urine, tamoxifen with 9-13 per cent in urine and 26-65 per cent in faeces, amongst others. In addition to the parent compounds, active metabolites, which are potentially more potent, have been detected, such as endoxifen, 4-hydroxytamoxifen, hydroxymethotrexate, hydroxypaclitaxel and 2’,2’-difluorodeoxyuridine.

Occurrence in the Environment

After excretion, and depending on the compounds’ stability, anticancer drugs and their metabolites are released into the sewers and then discharged into the aquatic environment after treatment. The contamination of water with anticancer drugs could be derived from many sources, such as the pharmaceutical industry, hospitals and households’ wastes. Bearing in mind that the majority of these compounds don’t have a targeted mode of action against cancer cells, they can also affect normally dividing cells.

What’s in the Water?

For this reason, more attention is now being paid to the detection of anticancer drugs in rivers and lakes and their potential risk to aquatic life. The first study revealing the occurrence of the anticancer drugs cyclophosphamide and ifosfamide in hospital wastewater and municipal wastewater treatment plant was conducted in Germany in 1996. Since then, increasing focus has been paid to this class of pharmaceuticals, especially in Spain and the United Kingdom.

Numerous methods have been developed and validated to detect these trace concentrations in rivers and lakes. In general, the most commonly adopted analytical techniques for the detection of anticancer drugs are Gas Chromatography Tandem Mass Spectrometry (GC-MS/MS), Liquid Chromatography Tandem Mass Spectrometry (LC-MS/MS) and Inductively-Coupled Plasma Tandem Mass Spectrometry (ICP-MS/MS). LC-MS is predominantly used in preference to GC-MS in order to avoid the derivatisation step before the analysis. ICP-MS is exclusively used to quantify the total platinum in the sample, which could indicate the presence of platinum compounds that can be included in the cancer treatment regimen, such as cisplatin, carboplatin and oxaliplatin. These techniques have achieved notable performances with detection limits as low as ng/L.

What’s in the Water?

Nonetheless, in order to achieve this high sensitivity, sample treatment should be conducted to reduce interferences deriving from the environmental matrix and also to pre-concentrate the compounds of interest. This is mainly accomplished by Solid-Phase Extraction (SPE). Several SPE cartridges have been used for the extraction of anticancer drugs from environmental samples. The most used cartridge was Oasis HLB, as it is able to extract a high range of acidic, basic and neutral compounds. 

The most frequently detected compounds between 1996 and 2018 were cyclophosphamide, tamoxifen, ifosfamide and methotrexate, with concentrations ranging between 0.01 and 86,200 ng/L.

Removal from Wastewater 

As previously stated, the presence of anticancer drugs in the aquatic environment is due to their inefficient removal by treatment plants. Three types of treatments are usually provided in wastewater treatment plants: biological, physicochemical and chemical.

What’s in the Water?

Throughout the biological treatment process, microorganisms such as bacteria, fungi, yeasts and algae are used to decompose the chemical compounds. However, biodegradation of anticancer drugs has often not been fully documented for the majority of the compounds tested. Although megestrol, etoposide, doxorubicin and gemcitabine showed rapid and high removal rates, cyclophosphamide and ifosfamide have been shown to remain at similar concentration levels post-treatment.

“cyclophosphamide and ifosfamide have been shown to remain at similar concentration levels post-treatment”

Physicochemical treatments include membrane filtration and advanced oxidation procedures. The latter covers UV-based photodegradation, photooxidation, photocatalytic oxidation, electron beam radiation and nanoparticle treatment. Higher removal percentages have been observed for several anticancer drugs such as 5-fluorouracil, cyclophosphamide, etoposide, ifosfamide, capecitabine, irinotecan, paclitaxel and imatinib.

What’s in the Water?

Finally, chemical treatments consist of oxidation with reagents such as H2O2 and Fenton’s reagent, ozonation and electrolysis. These treatments have also recorded high removal rates for a wide range of anticancer drugs. Examples of compounds that achieved a removal rate higher than 95 per cent include 5-fluorouracil, capecitabine, tamoxifen, cyclophosphamide, erlotinib, methotrexate and imatinib, amongst others. In addition to that, a combination of treatments has been shown to be more effective when one treatment was not enough to remove certain compounds. However, this increase in removal was not very significant.

While physiochemical and chemical treatments have improved the removal rates of anticancer drugs, the production of toxic transformation products is considered a major limitation of these procedures. For example, after UV treatment, the toxicity of capecitabine can increase. The same effect was observed for cyclophosphamide and ifosfamide after photocatalytic treatment (UV/TiO2) and ozonation. Moreover, the combination of ozonation and UV treatment of tamoxifen has increased the toxicity of the sample by generating more toxic compounds than the parent compound itself.

“although many treatments have reported high removal rates for the anticancer drugs tested, complete elimination or degradation has not yet been achieved”

Conclusion 

In summary, with the continuous improvement in the sensitivity of the current analytical techniques, anticancer drugs have been detected in several countries and different water resources at very low concentration levels (ng/L). This has highlighted the apparent inefficiency of conventional water treatments to eliminate these trace concentrations completely. Although many treatments have reported high removal rates for the anticancer drugs tested, complete elimination or degradation has not yet been achieved. This calls for the development of cost-effective water treatments that can be easily implemented in wastewater treatment plants.

What’s in the Water?
What’s in the Water?

Until new advances in water treatments are available, the question remains unanswered as to whether these trace concentrations of anticancer drugs in the aquatic environment could impact life in rivers and lakes in the short and long term.


References

  1. Gomez Cortes, L., Marinov, D., Sanseverino, I., Navarro Cuenca, A., Niegowska, M., Porcel Rodriguez, E. and Lettieri, T., Selection of substances for the 3rd Watch List under the Water Framework Directive, EUR 30297 EN, Publications Office of the European Union, Luxembourg, 2020, ISBN 978-92-76-19425-5, doi:10.2760/240926, JRC121346.
  2. ATC/DDD Index 2022. (2021). WHO Collaborating Centre for Drug Statistics.
  3. Muhamad, N., & Na-Bangchang, K. (2020). Metabolite profiling in anticancer drug development: A systematic review. In Drug Design, Development and Therapy (Vol. 14, pp. 1401–1444). Dove Medical Press Ltd. https://doi.org/10.2147/DDDT.S221518
  4. Nassour, C., Barton, S. J., Nabhani-Gebara, S., Saab, Y., & Barker, J. (2019). Occurrence of anticancer drugs in the aquatic environment: a systematic review. Environmental Science and Pollution Research, (Vol. 27, pp. 1339–1347). https://doi.org/10.1007/s11356-019-07045-2
  5. Valente, J. V., Coelho, S., Pastorinho, M. R., & A. Sousa, A. C. (2022). Anticancer drugs in the environment: environmental levels and technological challenges. In Emerging Contaminants in the Environment – Challenges and Sustainable Practices, Chapter 3, (pp. 55-86). Elsevier. https://doi.org/10.1016/b978-0-323-85160-2.00006-8

Authors

Carla Nassour MSc, PhD student
Prof James Barker, Professor of Analytical Science
Dr Stephen J. Barton, Associate Professor
Dr Shereen Nabhani-Gebara, Associate Professor

Share this article

ABOUT THE AUTHOR

Carla Nassour MSc | Prof James Barker | Dr Shereen Nabhani-Gebara | Dr Stephen J. Barton | School of Life Sciences, Pharmacy and Chemistry, Kingston University, London

“Our research team at Kingston University has been investigating hospital wastewater as a major source of micro/nanopollutants and toxic chemicals. In developing countries, most hospitals do not have sophisticated wastewater treatment plants and the generated wastewater often goes into primitive septic tanks that end up draining into the soil and percolate to the aquatic bodies or the sea, causing serious environmental hazards. Wastewater from hospitals can contain traces of anything from viruses and multi-resistant bacteria to medical contrast agents and chemicals for cancer treatment. Small amounts of hormone-disrupting substances and other medicinal residues are also part of the mix that passes from patients through hospital toilets and into public sewer systems. Our research has been focussed
in analysing these discharges and developing technologies for their removal”.

POPULAR POSTS BY Carla Nassour MSc | Prof James Barker | Dr Shereen Nabhani-Gebara | Dr Stephen J. Barton | School of Life Sciences, Pharmacy and Chemistry, Kingston University, London

What’s in the Water?

Article

What’s in the Water?

Get email updates

Sign up for the AWE newsletter

Keep up-to-date through the power of email and receive the latest environmental monitoring product information and newsletter emails from AWE - Monitoring and Analysing the Impact of Industry on the Environment

"*" indicates required fields

Country
*
This field is for validation purposes and should be left unchanged.

FEATURED ARTICLES

Press Release

Blackline Safety and NevadaNano Reach Milestone in Deployment of Industry-First Sensors

Press Release

The Benefits of Using Refurbished Parts in Your Lab

Advertisement

SOCIAL MEDIA

AWE on Facebook

https://www.facebook.com/AWEIMagazine/

Advertisement

SOCIAL MEDIA

AWE on Twitter

Avatar AWE International Magazine @aweimagazine ·
25 Jan

Soil is a vital component of natural capital, hosting rich biodiversity and providing critical ecosystem services, such as food production, water purification and carbon storage.

Read more from the @EUEnvironment here:
https://www.aweimagazine.com/press-release/monitoring-soil-threats-in-europe/

#aweinternational #EEA #soil

Reply on Twitter 1618284319327543296 Retweet on Twitter 1618284319327543296 Like on Twitter 1618284319327543296 Twitter 1618284319327543296

Advertisement

SUBSCRIBE

Stay up to date with our newsletter

    • Keep up-to-date with Europe’s largest audited environmental monitoring magazine

 

    • Delivering the latest information on new products and emerging technologies related to industrial environmental monitoring.

 

This field is for validation purposes and should be left unchanged.

Subscribe

SUBSCRIBE TO AWE MAGAZINE

5 reasons to subscribe to our digital and print package

  • Stay up to date from anywhere in the world, with instant access to the latest issue straight from your phone, tablet or laptop.
  • Trust that you’re getting the best content from our range of internationally accredited authors.
  • Get full access to our archives and see how the environmental monitoring landscape has evolved with us over the years.
  • Enjoy our monthly newsletter curated with up-to-the-minute news and a selection of editor’s top picks.
  • Hot off the press and straight to your door – look forward to your own glossy copy of AWE, delivered five times a year
Subscribe View Subscription levels

STAY SAFE & INFORMED

Subscribe to the latest environmental monitoring articles, news, products and regulations

Find out more

Stay up to date with our newsletter

  • This field is for validation purposes and should be left unchanged.

ABOUT

  • About AWE
  • Advertise
  • Contact Us

YOUR ACCOUNT

Sign In Register Account Subscribe to AWE

RESOURCES

Request Media Pack

CONNECT

ACCREDITATIONS

Copyright Bay Publishing 2023. All Rights reserved.

Designed & Built by:
  • Terms & Conditions
  • Privacy Policy
  • Cookie Policy
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking “Accept”, you consent to the use of ALL the cookies.
Cookie settingsACCEPT
Manage consent

Privacy Overview

This website uses cookies to improve your experience while you navigate through the website. Out of these, the cookies that are categorized as necessary are stored on your browser as they are essential for the working of basic functionalities of the website. We also use third-party cookies that help us analyze and understand how you use this website. These cookies will be stored in your browser only with your consent. You also have the option to opt-out of these cookies. But opting out of some of these cookies may affect your browsing experience.
Necessary
Always Enabled
Necessary cookies are absolutely essential for the website to function properly. These cookies ensure basic functionalities and security features of the website, anonymously.
CookieDurationDescription
cookielawinfo-checbox-analytics11 monthsThis cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Analytics".
cookielawinfo-checbox-functional11 monthsThe cookie is set by GDPR cookie consent to record the user consent for the cookies in the category "Functional".
cookielawinfo-checbox-others11 monthsThis cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Other.
cookielawinfo-checkbox-necessary11 monthsThis cookie is set by GDPR Cookie Consent plugin. The cookies is used to store the user consent for the cookies in the category "Necessary".
cookielawinfo-checkbox-performance11 monthsThis cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Performance".
viewed_cookie_policy11 monthsThe cookie is set by the GDPR Cookie Consent plugin and is used to store whether or not user has consented to the use of cookies. It does not store any personal data.
Functional
Functional cookies help to perform certain functionalities like sharing the content of the website on social media platforms, collect feedbacks, and other third-party features.
Performance
Performance cookies are used to understand and analyze the key performance indexes of the website which helps in delivering a better user experience for the visitors.
Analytics
Analytical cookies are used to understand how visitors interact with the website. These cookies help provide information on metrics the number of visitors, bounce rate, traffic source, etc.
Advertisement
Advertisement cookies are used to provide visitors with relevant ads and marketing campaigns. These cookies track visitors across websites and collect information to provide customized ads.
Others
Other uncategorized cookies are those that are being analyzed and have not been classified into a category as yet.
SAVE & ACCEPT